AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Elicio Therapeutics, Inc. Director's Dealing 2021

Jul 20, 2021

33784_dirs_2021-07-20_12cdb15b-c3fb-484b-9089-c4edb05d9c59.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4/A — Form 4/A

Issuer: Angion Biomedica Corp. (ANGN)
CIK: 0001601485
Period of Report: 2021-07-14

Reporting Person: Rhodes Jennifer J (See Remarks)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	33020	Direct

Footnotes

F1: On July 15, 2021, the reporting person erroneously reported a sale of 431 shares of common stock that did not occur. Consequently, this amendment is being filed to correct the original Form 4 to reflect no transaction having occurred.